Company news

CeriBell, Inc. news in 2026

CeriBell, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Ceribell Reports Third Quarter 2026 Financial Results

November 3, 2026

Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution

November 2, 2026

Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

October 28, 2026

Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026

October 20, 2026

Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis

September 30, 2026

Ceribell Reports Second Quarter 2026 Financial Results

August 10, 2026

Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System

August 3, 2026

Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O'Keefe

July 30, 2026

Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe

July 29, 2026

Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference

July 28, 2026

Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026

July 20, 2026

Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes

June 8, 2026

Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference

May 20, 2026

Ceribell Reports First Quarter 2026 Financial Results

May 11, 2026

Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference

April 29, 2026

Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026

April 20, 2026

Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results

February 24, 2026

Ceribell to Participate in Upcoming March Investor Conferences

February 18, 2026

Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

February 10, 2026

Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution

January 5, 2026

Calls in 2026

Decks in 2026